Stay updated on Treprostinil Inhalation Powder in PAH Clinical Trial
Sign up to get notified when there's something new on the Treprostinil Inhalation Powder in PAH Clinical Trial page.

Latest updates to the Treprostinil Inhalation Powder in PAH Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new Revision: v3.4.2 was added to the history; Revision: v3.4.1 and the government funding notice were removed.SummaryDifference0.5%

- Check20 days agoChange DetectedAdded a government funding lapse notice with the NIH Clinical Center status and a pointer to opm.gov; updated the site revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedAdded UI text for showing the glossary and color-coding changes (green/red highlights) and the revision note 'Revision: v3.4.0'. Removed the older notes 'No FEAR Act data' and 'Revision: v3.3.4'.SummaryDifference0.6%

- Check42 days agoChange DetectedThe page history now shows a new revision entry v3.3.4 added and the previous v3.3.3 entry removed. This change is limited to version labels and does not alter the study details or user-facing content.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.3.3 was added to the page footer. The HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check91 days agoChange DetectedThe History page adds a new revision entry (v3.3.2) and removes the previous entry (v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Treprostinil Inhalation Powder in PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Treprostinil Inhalation Powder in PAH Clinical Trial page.